New tools for functional mammalian cancer genetics
Open accessThe DOI matches its Crossref record; 73 of the 75 references it cites were found in a registry or an index.
Abstract
Knowledge of the function of individual genes that encode components of cell-signalling pathways is crucial to our understanding of normal growth control and its deregulation in cancer, but we have functional information for only 15% of human genes at present. Several new technologies have recently become available to identify gene function in mammalian cells using high-throughput genetic screens. These new tools will make it possible to identify new and innovative classes of anticancer drugs, including those that show synthetic lethal interactions with cancer-specific mutations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Almost all of the immortal cell clones that emerge have defects in either p53 or one of its upstream regulators or downstream effectors (16,17)”
From Glycolytic Enzymes Can Modulate Cellular Life Span (2005) · cites this paper as [16]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429 · cited 1×
“The discovery of a cellular response against double-stranded RNA 37 , however, has provided one of the most powerful tools to turn off gene expression, and this has revolutionized loss-of-function genetics, initially in C. elegans and Drosophila and also more recently in mammalian cells.”
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456 · cited 1×
“…(for example , a yeast two-hybrid screen) is required to identify the cellular protein that is affected by the interaction with the selected short peptide. short RNAs can recruit mammalian RISC to target mRNAs and induce their specific degradation, but do not activate the γ -interferon pathway 45 .”
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451 · cited 2×
“The discovery of methods to introduce foreign DNA into mammalian cells, now some 30 years ago, provided the first powerful tools to study gene function on a large scale 4 .”
Functional profiling of the Saccharomyces cerevisiae genome
Giaever, G., Chu, A. M., Ni, L., Connelly, C., Riles, L., Véronneau, S., Dow, S., Lucau-Danila, A., Anderson, K., André, B., et al. (2002) · Nature · doi:10.1038/nature00935 · Cited by 4,316 · cited 1×
“Molecular barcodes were first used in yeast genetic screens, in which large numbers of yeast genes were inactivated by insertion of a DNA segment that contained a unique 20-nucleotide sequence (the 'molecular barcode') to mark the individual knockout yeast strain”
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291 · cited 1×
“Several groups have effectively resolved these issues through the development of vector systems that mediate stable production of siRNA-like molecules in mammalian cells 46–50 (FIG.”
Self-citationFunctional Characterization of the S. cerevisiae Genome by Gene Deletion and Parallel Analysis
Winzeler, E. A., Shoemaker, D. D., Astromoff, A., Liang, H., Anderson, K., Andre, B., Bangham, R., Benito, R., Boeke, J. D., Bussey, H., et al. (1999) · Science · doi:10.1126/science.285.5429.901 · Cited by 3,953 · cited 1×
“Molecular barcodes were first used in yeast genetic screens, in which large numbers of yeast genes were inactivated by insertion of a DNA segment that contained a unique 20-nucleotide sequence (the 'molecular barcode') to mark the individual knockout yeast strain”
Systematic functional analysis of the Caenorhabditis elegans genome using RNAi
Kamath, R. S., Fraser, A. G., Dong, Y., Poulin, G., Durbin, R., Gotta, M., Kanapin, A., Le Bot, N., Moreno, S., Sohrmann, M., et al. (2003) · Nature · doi:10.1038/nature01278 · Cited by 3,616 · cited 1×
“Such large-scale genetic loss-of-function screens have allowed the identification of genes that affect worm development 40,41 , regulate fat storage 42 or serve to protect the genome against mutations 43 .”
Hannon, G. J. (2002) · Nature · doi:10.1038/418244a · Cited by 3,538
Expression profiling reveals off-target gene regulation by RNAi
Jackson, A. L., Bartz, S. R., Schelter, J., Kobayashi, S. V., Burchard, J., Mao, M., Li, B., Cavet, G., & Linsley, P. S. (2003) · Nature Biotechnology · doi:10.1038/nbt831 · Cited by 2,370 · cited 1×
“Some ‘off-target’side effects have been reported 60–62 , which in most cases can be attributed to partial homology of the un-intended target to the siRNA.”
Cited by
A General Framework for Weighted Gene Co-Expression Network Analysis
Zhang, B., & Horvath, S. (2005) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1128 · Cited by 5,684
“This facilitates novel strategies for screening for therapeutic targets (Brummelkamp and Bernards, 2003; Sonoda, 2003; Carter et al. , 2004; Mischel et al. , 2005).”
A large-scale RNAi screen in human cells identifies new components of the p53 pathway
Berns, K., Hijmans, E. M., Mullenders, J., Brummelkamp, T. R., Velds, A., Heimerikx, M., Kerkhoven, R. M., Madiredjo, M., Nijkamp, W., Weigelt, B., et al. (2004) · Nature · doi:10.1038/nature02371 · Cited by 1,065
Self-citationReversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
Sun, C., Wang, L., Huang, S., Heynen, G. J. J. E., Prahallad, A., Robert, C., Haanen, J., Blank, C., Wesseling, J., Willems, S. M., et al. (2014) · Nature · doi:10.1038/nature13121 · Cited by 888
Self-citationGlycolytic Enzymes Can Modulate Cellular Life Span
Kondoh, H., Lleonart, M. E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Carnero, A., & Beach, D. (2005) · Cancer Research · doi:10.1158/0008-5472.177.65.1 · Cited by 647
“one of its upstream regulators or downstream effectors (16, 17), in line with a direct involvement of p53 in the response to oxidative stress (18).”
BackgroundThe Fanconi Anemia/BRCA pathway: new faces in the crowd
Kennedy, R. D., & D'Andrea, A. D. (2005) · Genes & Development · doi:10.1101/gad.1370505 · Cited by 467
Metadata
- Authors
- Brummelkamp, T. R., & Bernards, R.
- Affiliations
- The Netherlands Cancer Institute (NL)
- Corresponding author
- Bernards, René
- Venue
- Nature Reviews Cancer
- Published
- 2003-12
- Volume
- 3
- Issue
- 10
- Pages
- 781-789
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2165874246
- Cited by
- 114
- References
- 75
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 3 · 2022: 4 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 3 · 2016: 2 · 2015: 3 · 2014: 6 · 2013: 5 · 2012: 2
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- green
- dspace.library.uu.nl
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Funders
- KWF Kankerbestrijding
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Keywords
- cancer genetics, gene function, cell signalling pathways, high-throughput genetic screens, anticancer drug discovery, synthetic lethality, tumor-specific mutations, mammalian cells
- MeSH terms
- Animals, Genetic Techniques, Humans, Mammals, Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New tools for functional mammalian cancer genetics. https://app.cochat.ai/papers/10.1038/nrc1191
- The paper
- Brummelkamp, T. R., & Bernards, R. (2003). New tools for functional mammalian cancer genetics. Nature Reviews Cancer. https://doi.org/10.1038/nrc1191
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.